Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre …

VC De Cock, P Dodet, S Leu-Semenescu… - The Lancet …, 2022 - thelancet.com
Background Insomnia is a frequent complaint of patients with Parkinson's disease, and it
negatively affects quality of life. Drugs that improve both sleep and parkinsonism would be of …

Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre …

VC de Cock, P Dodet, S Leu-Semenescu… - The Lancet …, 2022 - inria.hal.science
BACKGROUND: Insomnia is a frequent complaint of patients with Parkinson's disease, and
it negatively affects quality of life. Drugs that improve both sleep and parkinsonism would be …

Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre …

VC de Cock, P Dodet, S Leu-Semenescu, C Aerts… - The Lancet …, 2022 - hal.science
BACKGROUND: Insomnia is a frequent complaint of patients with Parkinson's disease, and
it negatively affects quality of life. Drugs that improve both sleep and parkinsonism would be …

Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre …

VC De Cock, P Dodet, S Leu-Semenescu, C Aerts… - 2022 - pubmed.ncbi.nlm.nih.gov
Background Insomnia is a frequent complaint of patients with Parkinson's disease, and it
negatively affects quality of life. Drugs that improve both sleep and parkinsonism would be of …

Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre …

VC De Cock, P Dodet, S Leu-Semenescu, C Aerts… - The Lancet …, 2022 - Elsevier
Background Insomnia is a frequent complaint of patients with Parkinson's disease, and it
negatively affects quality of life. Drugs that improve both sleep and parkinsonism would be of …

Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre …

VC De Cock, P Dodet, S Leu-Semenescu… - The Lancet …, 2022 - europepmc.org
Background Insomnia is a frequent complaint of patients with Parkinson's disease, and it
negatively affects quality of life. Drugs that improve both sleep and parkinsonism would be of …

Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre …

VC de Cock, P Dodet, S Leu-Semenescu… - The Lancet …, 2022 - ssa.hal.science
BACKGROUND: Insomnia is a frequent complaint of patients with Parkinson's disease, and
it negatively affects quality of life. Drugs that improve both sleep and parkinsonism would be …

Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre …

VC De Cock, P Dodet, S Leu-Semenescu… - The Lancet …, 2022 - thelancet.com
Background Insomnia is a frequent complaint of patients with Parkinson's disease, and it
negatively affects quality of life. Drugs that improve both sleep and parkinsonism would be of …